Test Catalog

Test ID: CMAMA    
Comprehensive Metabolic Panel, Serum

Useful For Suggests clinical disorders or settings where the test may be helpful

Routine health monitoring

 

Patient monitoring while hospitalized for information regarding metabolism, including the current kidney status, electrolyte and acid/base balance, and blood glucose

Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

The comprehensive metabolic panel measures 14 analytes and calculates an anion gap. It is used to assess kidney or liver status, electrolyte and acid/base balance, and blood glucose This comprehensive metabolic panel can also provide information about a patient's response to medications that would impact kidney or liver function.

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

SODIUM

<1 year: not established

> or =1 year: 135-145 mmol/L

 

POTASSIUM

<1 year: not established

> or =1 year: 3.6-5.2 mmol/L

 

CHLORIDE

<1 year: not established

1-17 years: 102-112 mmol/L

> or =18 years: 98-107 mmol/L

 

BICARBONATE

Males:

<1 year: not established

1-2 years: 17-25 mmol/L

3 years: 18-26 mmol/L

4-5 years: 19-27 mmol/L

6-7 years: 20-28 mmol/L

8-17 years: 21-29 mmol/L

> or =18 years: 22-29 mmol/L

 

Females:

<1 year: not established

1-3 years: 18-25 mmol/L

4-5 years: 19-26 mmol/L

6-7 years: 20-27 mmol/L

8-9 years: 21-28 mmol/L

> or =10 years: 22-29 mmol/L

 

ANION GAP

<7 years: not established

> or =7 years: 7-15

 

BLOOD UREA NITROGEN (BUN)

Males:

<12 months: not established

1-17 years: 7-20 mg/dL

> or =18 years: 8-24 mg/dL

 

Females:

<12 months: not established

1-17 years: 7-20 mg/dL

> or =18 years: 6-21 mg/dL

 

CREATININE

Males:

0-11 months: 0.17-0.42 mg/dL

1-5 years: 0.19-0.49 mg/dL

6-10 years: 0.26-0.61 mg/dL

11-14 years: 0.35-0.86 mg/dL

> or =15 years: 0.74-1.35 mg/dL

 

Females:

0-11 months: 0.17-0.42 mg/dL

1-5 years: 0.19-0.49 mg/dL

6-10 years: 0.26-0.61 mg/dL

11-15 years: 0.35-0.86 mg/dL

> or =16 years: 0.59-1.04 mg/dL

 

ESTIMATED GLOMERULAR FILTRATION RATE (eGFR)

>60 mL/min/BSA

Estimated GFR calculated using the 2009 CKD_EPI creatinine equation

 

CALCIUM

<1 year: 8.7-11.0 mg/dL

1-17 years: 9.3-10.6 mg/dL

18-59 years: 8.6-10.0 mg/dL

60-90 years: 8.8-10.2 mg/dL

>90 years: 8.2-9.6 mg/dL

 

GLUCOSE

0-11 months: not established

> or =1 year: 70-140 mg/dL

 

TOTAL PROTEIN

> or =1 year: 6.3-7.9 g/dL

Reference values have not been established for patients who are <12 months of age.

 

ALBUMIN

> or =12 months: 3.5-5.0 g/dL

Reference values have not been established for patients who are <12 months of age.

 

ASPARTATE AMINOTRANSFERASE (AST)

Males:

0-11 months: not established

1-13 years: 8-60 U/L

> or =14 years: 8-48 U/L

 

Females:

0-11 months: not established

1-13 years: 8-50 U/L

> or =14 years: 8-43 U/L

 

ALKALINE PHOSPHATASE (ALP)

Males:

4 years: 149-369 U/L

5 years: 179-416 U/L

6 years: 179-417 U/L

7 years: 172-405 U/L

8 years: 169-401 U/L

9 years: 175-411 U/L

10 years: 191-435 U/L

11 years: 185-507 U/L

12 years: 185-562 U/L

13 years: 182-587 U/L

14 years: 166-571 U/L

15 years: 138-511 U/L

16 years: 102-417 U/L

17 years: 69-311 U/L

18 years: 52-222 U/L

> or =19 years: 45-115 U/L

 

Females:

4 years: 169-372 U/L

5 years: 162-355 U/L

6 years: 169-370 U/L

7 years: 183-402 U/L

8 years: 199-440 U/L

9 years: 212-468 U/L

10 years: 215-476 U/L

11 years: 178-526 U/L

12 years: 133-485 U/L

13 years: 120-449 U/L

14 years: 153-362 U/L

15 years: 75-274 U/L

16 years: 61-264 U/L

17-23 years: 52-144 U/L

24-45 years: 37-98 U/L

46-50 years: 39-100 U/L

51-55 years: 41-108 U/L

56-60 years: 46-118 U/L

61-65 years: 50-130 U/L

> or =66 years: 55-142 U/L

Reference values have not been established for patients that are <4 years of age.

 

ALANINE AMINOTRANSFERASE (ALT)

Males:

> or =1 year: 7-55 U/L

Reference values have not been established for patients who are <12 months of age.

 

Females:

> or =1 year: 7-45 U/L

Reference values have not been established for patients who are <12 months of age.

 

TOTAL BILIRUBIN

0-6 days: Refer to http://bilitool.org/ for information on age-specific (postnatal hour of life) serum bilirubin values.

7-14 days: <15.0 mg/dL

15 days to 17 years: < or =0.9 mg/dL

>18 years: < or =1.2 mg/dL

Interpretation Provides information to assist in interpretation of the test results

Comprehensive metabolic panel results are usually evaluated in conjunction with each other for patterns of results. The pattern of abnormal results can help identify the possible conditions or diseases present. Many conditions will cause abnormal results including kidney failure, breathing problems, and diabetes-related complications.

Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances

No significant cautionary statements.

Clinical Reference Recommendations for in-depth reading of a clinical nature

AACC: Lab Tests Online: Access 03/22/2017. Available from https://labtestsonline.org/understanding/analytes/cmp